Jindong Dai
A5044016786- Renal cell carcinoma treatment
- Epigenetics and DNA Methylation
- Phagocytosis and Immune Regulation
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Urologic and reproductive health conditions
- Cancer Immunotherapy and Biomarkers
- Renal and related cancers
- Cancer-related molecular mechanisms research
- Ferroptosis and cancer prognosis
- MRI in cancer diagnosis
- Computational and Text Analysis Methods
- Machine Learning in Healthcare
- Carbon and Quantum Dots Applications
- Luminescence and Fluorescent Materials
- Advanced biosensing and bioanalysis techniques
- Hepatocellular Carcinoma Treatment and Prognosis
- Brain Tumor Detection and Classification
- EEG and Brain-Computer Interfaces
- Bladder and Urothelial Cancer Treatments
- Radiomics and Machine Learning in Medical Imaging
Sichuan University
2022-2025
West China Hospital of Sichuan University
2022-2025
Jiangsu University
2024
333 Background: The objective of this study is to develop prediction models and provide diagnostic results for prostate biopsy among patients. Methods: This paper presents an improved tree model, called the Light gradient boosting machine building a cancer (PCa) risk model. research data used in (Waves 2008-2022) are obtained from 1987 patients who underwent transperineal at West China Hospital. All had indications (high levels specific antigen (PSA), suspect lesions magnetic resonance...
Abstract Intraductal carcinoma of the prostate (IDC-P) is a lethal cancer subtype that generally coexists with invasive high-grade acinar adenocarcinoma (PAC) but exhibits distinct biological features compared concomitant adenocarcinoma. In this study, we performed whole-exome, RNA, and DNA-methylation sequencing IDC-P, concurrent PAC lesions, adjacent normal tissues isolated from 22 radical prostatectomy specimens. Three evolutionary patterns IDC-P were identified: early divergent, late...
Abstract Purpose: Fumarate hydratase–deficient renal cell carcinoma (FH-deficient RCC) is a rare and lethal subtype of kidney cancer. However, the optimal treatments molecular correlates benefits for FH-deficient RCC are currently lacking. Experimental Design: A total 91 patients with from 15 medical centers between 2009 2022 were enrolled in this study. Genomic bulk RNA-sequencing (RNA-seq) performed on 88 45 untreated RCCs, respectively. Single-cell RNA-seq was to identify biomarkers...
<p>Table S6</p>
<p>Table S4</p>
<p>Table S3</p>
<p>Supplementary Methods</p>
<p>Table S4</p>
<p>Table S1-revised</p>
<p>Supplementary Methods</p>
<p>Table S5</p>
<div>Abstract<p>Intraductal carcinoma of the prostate (IDC-P) is a lethal cancer subtype that generally coexists with invasive high-grade acinar adenocarcinoma (PAC) but exhibits distinct biological features compared concomitant adenocarcinoma. In this study, we performed whole-exome, RNA, and DNA-methylation sequencing IDC-P, concurrent PAC lesions, adjacent normal tissues isolated from 22 radical prostatectomy specimens. Three evolutionary patterns IDC-P were identified: early...
<p>Table S7</p>
<div>Abstract<p>Intraductal carcinoma of the prostate (IDC-P) is a lethal cancer subtype that generally coexists with invasive high-grade acinar adenocarcinoma (PAC) but exhibits distinct biological features compared concomitant adenocarcinoma. In this study, we performed whole-exome, RNA, and DNA-methylation sequencing IDC-P, concurrent PAC lesions, adjacent normal tissues isolated from 22 radical prostatectomy specimens. Three evolutionary patterns IDC-P were identified: early...
<p>Supplementary figure 1-15</p>
<p>Table S8</p>
<p>Supplementary figure 1-15</p>
<p>Table S5</p>
<p>Table S1-revised</p>
<p>Table S6</p>
<p>Table S2-revised</p>
<p>Table S8</p>
<p>Table S2-revised</p>